Boston Scientific Shares Fall as CEO Flags Short-Term Challenges
MT Newswires Live
May 27
Boston Scientific (BSX) shares fell 9% in Wednesday trading after Chief Executive Mike Mahoney said this year has been "a bit more of a challenge" than anticipated.
Mahoney said at an industry conference Wednesday that the company is "not going to likely grow faster than our peer group in the short term, but as that Denali platform gets launched in our emblem with [subcutaneous implantable cardioverter defibrillator] leadless pacemaker, that will help our growth in our [cardiac rhythm management] business," according to a FactSet transcript.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.